Skip to main content
    I

    Invivyd Inc. (IVVD)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.54
    -0.04 (-7.63%)

    Market Cap: $171.58M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Invivyd Inc. (IVVD) Financials: Revenue, Profit and Cash Flow

    Updated Nov 12, 2026. Financial statements from company filings, amounts in US dollars.

    Invivyd reported revenue of $53.43M for the fiscal year ended Dec 31, 2025, up 110.5% from the year before. That year, net income was -$52.49M with a net margin of -98.2%, operating cash flow was -$58.13M and free cash flow was -$58.29M. The quarter ended Sep 30, 2026 had revenue of $15.45M and net income of -$33.47M.

    Revenue and Margins

    The net margin was -98.2% in the fiscal year ended Dec 2025.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$53.43M+110.5%93.0%-104.0%-98.2%
    Dec 2024$25.38MN/A93.6%-696.8%-669.4%
    Dec 2023$0N/AN/AN/AN/A
    Dec 2022$0N/AN/AN/AN/A
    Dec 2021$0N/AN/AN/AN/A
    Dec 2020N/AN/AN/AN/AN/A
    Annual, fiscal years ended Dec 2020 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
    Revenue$53.43M$25.38M$0$0$0N/A
    Cost of revenue$3.75M$1.62M$0$0$0N/A
    Gross profit$49.68M$23.77M$0$0$0N/A
    Research and development$38.31M$137.25M$163.63M$183.61M$190.39M$106.49M
    Operating income-$55.56M-$176.88M-$212.76M-$248.03M-$226.91M-$111.99M
    Net income-$52.49M-$169.93M-$198.64M-$241.32M-$226.79M-$111.98M
    EBITDA-$50.38M-$166.81M-$197.74M-$242.88M-$225.36M-$65.33M
    Fiscal years ended Dec 2020 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$15.45M$14.29M$13.74M$17.21M$13.13M$11.79M$11.30M$13.82M$9.30M$2.26M$0$3.02M
    Gross profit$14.41M$13.01M$12.71M$16.07M$12.04M$11.10M$10.47M$13.10M$8.49M$2.18M$0$2.51M
    Operating income-$34.68M-$45.82M-$43.14M-$12.55M-$11.02M-$15.06M-$16.92M-$19.23M-$62.31M-$49.25M-$46.09M-$76.75M
    Net income-$33.47M-$44.39M-$41.40M-$11.07M-$10.47M-$14.66M-$16.29M-$18.44M-$60.74M-$47.25M-$43.50M-$73.65M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $1.31M by $225.38M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
    Total assets$276.88M$129.51M$229.18M$383.17M$620.09M$117.38M
    Current assets$247.47M$100.68M$224.88M$376.92M$616.71M$117.38M
    Cash and equivalents$226.69M$69.35M$200.64M$92.08M$542.22M$114.99M
    Total liabilities$35.34M$61.98M$51.71M$27.20M$62.07M$13.08M
    Short-term debt$1.31M$1.30M$1.44M$1.56MN/AN/A
    Shareholder equity$241.54M$67.54M$177.47M$355.97M$558.02M-$65.25M
    Fiscal years ended Dec 2020 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$183.91M$218.88M$241.74M$276.88M$139.16M$89.14M$103.74M$129.51M$161.92M$177.35M$215.47M$229.18M
    Total liabilities$33.42M$37.80M$38.69M$35.34M$46.09M$46.35M$49.59M$61.98M$78.76M$36.70M$36.97M$51.71M
    Cash and equivalents$126.40M$160.08M$184.15M$226.69M$84.97M$34.91M$48.08M$69.35M$106.87M$147.88M$189.39M$200.64M
    Shareholder equity$150.48M$181.08M$203.05M$241.54M$93.07M$42.79M$54.15M$67.54M$83.16M$140.64M$178.50M$177.47M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
    Operating cash flow-$58.13M-$170.49M-$173.16M-$219.99M-$184.74M-$14.57M
    Capital expenditures$155.00K$140.00K$615.00K$1.71M$84.00K$84.00K
    Free cash flow-$58.29M-$170.63M-$173.78M-$221.69M-$184.82M-$14.65M
    Share repurchasesN/AN/A$1.00K$4.00K$0N/A
    Investing cash flow-$155.00K-$140.00K$280.68M-$230.67M-$50.71M-$50.71M
    Financing cash flow$215.63M$39.33M$1.04M$506.00K$662.68M$129.56M
    Fiscal years ended Dec 2020 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$32.11M-$43.01M-$41.71M-$15.46M-$8.25M-$13.30M-$21.13M-$37.61M-$41.07M-$41.60M-$50.21M-$59.24M
    Capital expenditures$585.00K$510.00K$726.00K$0$0$11.00K$144.00K$5.00K$5.00K$0$140.00K$0
    Free cash flow-$32.70M-$43.52M-$42.44M-$15.46M-$8.25M-$13.31M-$21.27M-$37.62M-$41.07M-$41.60M-$50.35M-$59.24M
    Last 12 quarters

    Frequently Asked Questions About IVVD

    What is Invivyd's annual revenue?

    Invivyd reported revenue of $53.43M for the fiscal year ended Dec 31, 2025.

    How fast is Invivyd's revenue growing?

    Revenue was up 110.5% for the fiscal year ended Dec 31, 2025 compared with the year before.

    Is Invivyd profitable?

    No. Invivyd reported net income of -$52.49M for the fiscal year ended Dec 31, 2025, with a net margin of -98.2%.

    How much free cash flow does IVVD generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$58.13M minus capital expenditures of $155.00K produced free cash flow of -$58.29M.

    How much debt does Invivyd have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $1.31M and cash and equivalents of $226.69M.